Viskase Holdings, Inc.
Data quality: 100%
$6.00
▲
$0.45
(8.11%)
Mkt Cap: 4.45 M
Price
$6.00
Mkt Cap
4.45 M
Day Range
$0.05 — $0.06
52-Week Range
$0.05 — $12.99
Volume
207,734
Open $0.06
50D / 200D Avg
$6.23
3.74% below
50D / 200D Avg
$6.73
10.85% below
Quick Summary
Key Takeaways
Revenue declined -56.12% annually over 5 years
Earnings declined -538.17% over the past year
Negative free cash flow of -3.01 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 56.12%
Growth
Revenue Growth (5Y)
-56.12%
Below sector avg (1.82%)
Revenue (1Y)0.00%
Earnings (1Y)-538.17%
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-9.63%
Net Margin-13111.54%
Op. Margin-20426.92%
Safety
Debt / Equity
N/A
Current Ratio80.86
Interest CoverageN/A
Valuation
PE (TTM)
-1.31
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.3 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.3 |
| Net Margin % | -13111.5 | -41.5 |
| Rev Growth 5Y % | -56.1 | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.00% | Revenue Growth (3Y) | 0.00% |
| Earnings Growth (1Y) | -538.17% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -56.12% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 26,000.0 | Net Income (TTM) | -3.41 M |
| ROE | N/A | ROA | -7.71% |
| Gross Margin | N/A | Operating Margin | -20426.92% |
| Net Margin | -13111.54% | Free Cash Flow (TTM) | -3.01 M |
| ROIC | -9.63% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 80.86 |
| Interest Coverage | N/A | Asset Turnover | 0.00 |
| Working Capital | 43.13 M | Tangible Book Value | -923,000 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.31 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 171.26 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -67.60% | ||
| Market Cap | 4.45 M | Enterprise Value | -38.80 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.07 | Revenue / Share | 0.04 |
| FCF / Share | -4.06 | OCF / Share | -4.06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 88.30% |
| SBC-Adj. FCF | N/A | Growth Momentum | 56.12 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 26,000.0 | 26,000.0 | 26,000.0 | 26,000.0 | 701,000.0 |
| Net Income | -3.41 M | 778,000.0 | 1.37 M | -186,000.0 | -469,000.0 |
| EPS (Diluted) | -0.07 | -0.01 | 0.00 | -0.02 | -0.03 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -5.31 M | -1.33 M | -1.04 M | -1.03 M | -469,000.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 19,000.0 | 347,000.0 | -156,000.0 | -200,000.0 | 7,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 42.81 M | 47.17 M | 47.70 M | 47.59 M | 47.75 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | -2.53 M | 3.01 M | 3.51 M | 3.41 M | 4.87 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 42.57 M | 46.86 M | 47.01 M | 46.98 M | 47.64 M |
| Current Assets | 42.81 M | 47.15 M | 47.34 M | 47.39 M | — |
| Current Liabilities | 731,000.0 | 1.68 M | 1.71 M | 1.70 M | 403,000.0 |
{"event":"ticker_viewed","properties":{"ticker":"ENZN","listing_kind":"stock","pathname":"/stocks/enzn","exchange":"OTC","country":"US"}}